SPARCL1 and obesity disorder: This effect may lead to enhanced adipocyte hypertrophy in obesity (Meissburger et al., 2016; Xiao et al., 2021), suggesting that SPARCL1 controls adipogenesis in a paracrine/autocrine manner.